pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
XB-010
Endometrial Cancer
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
XB-371
Solid Tumor
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
XB-628
Solid Tumor
$EXELEXELIXIS, INC.
0 catalysts
Preclinical
← prev
page 176 of 271
next →
131
Pain89
Neurology1
XBIO-020
Hematological Tumor
$XBIOXenetic Biosciences, Inc.
0 catalysts
Preclinical
XDC Conjugate Drugs
Unspecified
Aojin Life Sciences (Yixing) Co Ltd
0 catalysts
XELJANZ
XELJANZ (TOFACITINIB CITRATE)
1 INDICATIONS AND USAGE XELJANZ (tablets and oral solution) and XELJANZ XR (e…
Janus Kinase (JAK)
$PFEPFIZER INC
0 catalysts
XELJANZ XR
XELJANZ XR (TOFACITINIB CITRATE)
1 INDICATIONS AND USAGE XELJANZ (tablets and oral solution) and XELJANZ XR (e…
Janus Kinase (JAK)
$PFEPFIZER INC
0 catalysts
XENON, XE-133
XENON, XE-133 (XENON)
CURIUM
0 catalysts
Phase 3
XG-005
Post-Operative Pain
Xgene Pharmaceutical Inc
0 catalysts
Preclinical
XJ-MK-001
Thrombocytopenia
HemaCell Biotechnology Inc
0 catalysts
Phase 1
XKH-002
Solid Tumor
Zhejiang Xinkanghe Biomedical Technology Co Ltd
0 catalysts
Phase 1
XL-309
Fallopian Tube Cancer
$EXELEXELIXIS, INC.
0 catalysts
Preclinical
XLNT-1
Metastatic Ovarian Cancer
Nami Therapeutics Corp
0 catalysts
Preclinical
XLRS Gene Therapy Program
Retinal Degeneration
TeamedOn International Inc
0 catalysts
Preclinical
XM-14601
Pancreatic Ductal Adenocarcinoma
Excellamol Inc
0 catalysts
Preclinical
XM-161SN38
High-Grade Glioma
Excellamol Inc
0 catalysts
XPOVIO
XPOVIO (SELINEXOR)
1 INDICATIONS AND USAGE XPOVIO is a nuclear export inhibitor indicated: In co…
Exportin-1
$KPTIKaryopharm Therapeutics Inc.
0 catalysts
Phase 2
XRX-101
oxypurinol
Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury
Xanthine dehydrogenase/oxidase
$XRTXXORTX Therapeutics Inc.
0 catalysts
Phase 3
XRx-026
oxypurinol
Gouty Arthritis (Gout)
Xanthine dehydrogenase/oxidase
$XRTXXORTX Therapeutics Inc.
0 catalysts
Phase 3
XT-150
Osteoarthritis Pain
Xalud Therapeutics Inc
0 catalysts
XTAMPZA ER
XTAMPZA ER (OXYCODONE)
1 INDICATIONS AND USAGE XTAMPZA ER is indicated for the management of severe…
Mu-type opioid receptor
$COLLCOLLEGIUM PHARMACEUTICAL, INC
0 catalysts
XTANDI
XTANDI (ENZALUTAMIDE)
Astellas Pharma Inc
0 catalysts
Preclinical
XTX-501
Non-Small Cell Lung Cancer
$XLOXilio Therapeutics, Inc.
0 catalysts
Phase 1
XW-014
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Hangzhou Sciwind Biosciences Co Ltd
0 catalysts
Preclinical
XYA-01
Triple-Negative Breast Cancer (TNBC)
Xyone Therapeutics Inc
0 catalysts
Preclinical
XYA-02
Pancreatic Ductal Adenocarcinoma
Xyone Therapeutics Inc
0 catalysts
Marketed
Xalox
Oxaliplatin (oxaliplatin)
Colon Cancer
Teva Pharmaceuticals USA Inc
0 catalysts
Marketed
Xanax
Alprazolam Greenstone (alprazolam)
Anxiety Disorders
Greenstone LLC
0 catalysts
Marketed
Xanax XR
Xanax XR (alprazolam)
Agoraphobia
$VTRSViatris Inc
0 catalysts
Marketed
Xarelto
Xarelto (rivaroxaban)
Atrial Fibrillation
Johnson & Johnson Innovative Medicine
0 catalysts